Aurobindo Pharma arm bags USFDA nod for cancer drug Bortezomib Ruchika Sharma4 May 2022 11:00 AM ISTHyderabad: Drugmaker, Aurobindo Pharma Limited, has recently announced that its wholly owned subsidiary company, Eugia Pharma Specialties...
AstraZeneca to study cancer drug Datopotamab deruxtecan in India Medical Dialogues Team27 Dec 2021 6:39 PM ISTNew Delhi: In a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under...
AstraZeneca receives CDSCO panel nod to conduct phase 3 trial of Trastuzumab Deruxtecan Roshni Dhar1 Dec 2021 3:47 PM ISTIn a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under the Central...
Health Bulletin 30/November/2021 Roshni Dhar30 Nov 2021 5:38 PM ISTHere are top Health stories of the dayCourt junks plea of 2 Accused in PGIMER MD seat scam, finds Prima Facie Case against 27In the latest development...
AstraZeneca gets CDSCO panel nod to conduct cancer drug Trastuzumab Deruxtecan study Medical Dialogues Team29 Nov 2021 6:21 PM ISTNew Delhi: In a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under...
Erbitux, adagrasib combination shrinks tumors in 39 percent of colon cancer patients: Mirati Therapeutics Ruchika Sharma20 Sept 2021 10:15 AM ISTNew Delhi: A combination of Mirati Therapeutics Inc's genetic mutation-targeting adagrasib and older cancer drug Erbitux shrank tumors in 39% of...
Reduced GST rates on COVID drugs extended till December Ruchika Sharma18 Sept 2021 5:44 PM ISTLucknow: The GST Council on Friday extended concessional tax rates on COVID-19 medicines, cut tax on cancer drugs and waived GST on import of highly...
Sun Pharma gets CDSCO panel nod to additional pack size of Gemcitabine Medical Dialogues Team16 Aug 2021 2:00 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
JnJ cancer drug Amivantamab gets CDSCO panel okay with waiver of local phase 3,4 trials Medical Dialogues Team14 Aug 2021 3:25 PM ISTNew Delhi: Considering an unmet medical need in the country, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
Zydus Cadila breast cancer drug Fulvestrant gets USFDA okay Medical Dialogues Bureau31 July 2021 1:33 PM ISTZydus Cadila said Fulvestrant Injection will be manufactured at the group's formulation manufacturing facility at Zydus Biologics, Ahmedabad.
Sun Pharma cancer drug Pemetrexed Solution for Infusion gets CDSCO panel okay Medical Dialogues Team23 July 2021 6:23 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
NPPA gets Delhi HC notice on AstraZeneca plea over cancer drug Tagrisso Ruchika Sharma15 July 2021 1:28 PM ISTNew Delhi: The Delhi High Court on Monday issued notice to National Pharmaceutical Pricing Authority (NPPA) and others on AstraZeneca Pharma India's...
